NCT01442012

Brief Summary

To evaluate the Utility of Acupuncture in the Treatment of Postoperative Nausea and Vomiting (PONV) in Ambulatory Surgery.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
270

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Sep 2011

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2011

Completed
25 days until next milestone

First Submitted

Initial submission to the registry

September 26, 2011

Completed
2 days until next milestone

First Posted

Study publicly available on registry

September 28, 2011

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2012

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2013

Completed
Last Updated

October 3, 2012

Status Verified

October 1, 2012

Enrollment Period

1.3 years

First QC Date

September 26, 2011

Last Update Submit

October 2, 2012

Conditions

Keywords

PONVACUPUNCTURE

Outcome Measures

Primary Outcomes (1)

  • Percentage of patients with a score <50 on the PONV Intensity Scale at 72 hours postoperatively.

    The percentage of patients with a score \<50 on the PONV Intensity Scale (defined as clinically not significant PONV) at 72 hours postoperatively will be assessed in the experimental and control group, respectively. In the experimental group, patients receive cutaneous stimulation and self-stimulation of acupuncture points Pericardium 6, Heart 7 and Stomach 25. In the control (placebo) group, patients receive cutaneous stimulation and self-stimulation of acupuncture points Gall Bladder 34, Kidney 6 and Liver 3.

    72 hours

Secondary Outcomes (6)

  • Percentage of patients with a score <50 on the PONV Intensity Scale at 6 and 24 hours postoperatively.

    6 and 24 hours

  • Evaluation of the postoperative recovery outcome

    24 hours

  • Evaluation of perioperative pain

    72 hours

  • Assessment of the patient´s satisfaction with the perioperative care

    72 hours

  • Assessment of costs and economic impact of the disease

    72 hours

  • +1 more secondary outcomes

Study Arms (2)

Group A

ACTIVE COMPARATOR

Patients receive cutaneous stimulation and self-stimulation of acupuncture points Pericardium 6, Heart 7 and Stomach 25

Other: Ear seeds

Group B

SHAM COMPARATOR

Patients receive cutaneous stimulation and self-stimulation of acupuncture points Gall Bladder 34, Kidney 6 and Liver 3

Other: Ear seeds

Interventions

The investigators will use ear seeds to stimulate acupuncture points. The seeds will be applied when the patients are in the preoperative room. After the patients have been discharged, they will need to stimulate these points every eight hours for five minutes, and every time they have nausea and/or vomiting during the first three postoperative days.

Group AGroup B

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients of both sexes, aged 18 years and older.
  • ASA I-II patients who will undergo a surgical procedure under general anesthesia in an ambulatory setting.
  • Patients who are anticipated to not require admission to the recovery room or intensive care unit.
  • Patients who, according to clinical criteria of the acupuncturist physician, are likely to benefit from acupuncture.
  • Patients with a sufficient educational level to complete the health questionnaires required in the study.
  • Patients who have given their written informed consent to participate in the study.

You may not qualify if:

  • Patients with any pathology that under medical discretion makes their participation in the study inadvisable.
  • Patients who cannot respond to the questionnaires provided during the study.
  • Patients with known hypersensitivity to the materials of the ear seeds.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fundacion Jimenez Diaz Hospital

Madrid, Madrid, 28040, Spain

RECRUITING

MeSH Terms

Conditions

Postoperative Nausea and Vomiting

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsNauseaSigns and Symptoms, DigestiveSigns and SymptomsVomiting

Study Officials

  • PAULA ORTIZ LUCAS, MD

    GRUPO G6

    PRINCIPAL INVESTIGATOR

Central Study Contacts

PAULA ORTIZ LUCAS, MD

CONTACT

VALENTIN MARTIN, MD, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
NETWORK
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 26, 2011

First Posted

September 28, 2011

Study Start

September 1, 2011

Primary Completion

December 1, 2012

Study Completion

April 1, 2013

Last Updated

October 3, 2012

Record last verified: 2012-10

Locations